Evidence map›Paper›PMID 18415027›Full record

ArticleFamilial cancer2008

Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas.

Marjo van Puijenbroek, Anneke Middeldorp, Carli M J Tops, Ronald van Eijk, Heleen M van der Klift, Hans F A Vasen, Juul Th Wijnen, Frederik J Hes, Jan Oosting, Tom van Wezel and 1 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Familial cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Marjo van PuijenbroekDepartment of Pathology, Leiden University Medical Center, Building L1Q, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Anneke Middeldorp
Carli M J Tops
Ronald van Eijk
Heleen M van der Klift
Hans F A Vasen
Juul Th Wijnen
Frederik J Hes
Jan Oosting
Tom van Wezel
Hans Morreau
Leiden University Medical Center · NLNetherlands Consortium for Healthy Ageing · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mismatch repair deficiency in tumors can result from germ line mutations in one of the mismatch repair (MMR) genes (MLH1, MSH2, MSH6 and PMS2), or from sporadic promoter hypermethylation of MLH1. The role of unclassified variants (UVs) in MMR genes is subject to debate. To establish the extend of chromosomal instability and copy neutral loss of heterozygosity (cnLOH), we analyzed 41 archival microsatellite unstable carcinomas, mainly colon cancer, from 23 patients with pathogenic MMR mutations, from eight patients with UVs in one of the MMR genes and 10 cases with MLH1 promoter hypermethylation. We assessed genome wide copy number abnormalities and cnLOH using SNP arrays. SNP arrays overcome the problems of detecting LOH due to instability of polymorphic microsatellite markers. All carcinomas showed relatively few chromosomal aberrations. Also cnLOH was infrequent and in Lynch syndrome carcinomas usually confined to the locus harbouring pathogenic mutations in MLH1, MSH2 or PMS2 In the carcinomas from the MMR-UV carriers such cnLOH was less common and in the carcinomas with MLH1 promoter hypermethylation no cnLOH at MLH1 occurred. MSI-H carcinomas of most MMR-UV carriers present on average with more aberrations compared to the carcinomas from pathogenic MMR mutation carriers, suggesting that another possible pathogenic MMR mutation had not been missed. The approach we describe here shows to be an excellent way to study genome-wide cnLOH in archival mismatch repair deficient tumors.

Indexed as

DNA Mismatch RepairLoss of HeterozygosityMicrosatellite InstabilityAdaptor Proteins, Signal TransducingAdultAgedAged, 80 and overCarcinomaColonic NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisDNA MethylationGene DosageHumansMiddle AgedMutL Protein Homolog 1Nuclear ProteinsAdaptor Proteins, Signal TransducingMLH1 protein, humanMutL Protein Homolog 1Nuclear Proteins

Identifiers

PMID18415027
OpenAlexW2027309683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.